Myomar Molecular Inc.: federal grants and contributions: 8 agreements; $1.1M value; 3 departments; 5 programs.
Assay record ASY-CA-0JIOS3A0C4 · Cite as: Assay Systems, “Myomar Molecular Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/myomar-molecular-inc/
Supporting a Northern Ontario company to hire a STEM professional and undertake late-stage product development, manufacturing readiness, and market launch activities for a dual-use remote health monitoring product targeting consumer, space, and defence markets.
Our project encompasses the development of a novel technology to monitor muscle health, which is directly connected to quality of life and longevity. Our technology will facilitate both preventative and targeted treatment strategies.
Develop a novel technology to analyze and report muscle health
This project aims to develop Myomar’s own laboratory biomarker quantification assays to reduce dependence on commercial enzymatic kits.
This project will identify specific diagnostic platforms that will be used to measure the presence of biomarkers in human samples. These biomarkers are linked to muscular atrophy.
Engage expertise to validate technology using targeted piloting trials
Engage expertise to refine test accuracy and gather data
Engage senior software developer to build predictive analytics
All grants from Federal Economic Development Agency for Northern Ontario
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.